Table 3.

Delphi Panelist Characteristics

Round 1 (n = 54)Round 2 (n = 49)
Gender
 Female3157%3061%
 Male2241%1837%
 Other12%12%
Profession/background
 Brain Cancer Carer611%48%
 Brain Cancer Patient47%36%
 Medical Oncologist917%918%
 Neuro-Oncologist24%24%
 Neuropathologist36%36%
 Neurosurgeon611%48%
 Nurse Consultant12%12%
 Other713%714%
 Palliative Care Clinician24%24%
 Radiation Oncologist59%510%
 Radiologist12%12%
 Rehabilitation Clinician12%12%
 Research/Public Health59%510%
 Social Worker12%12%
 Trainee12%12%
Geographic location
 Metropolitan4889%4592%
 Regional611%48%
Membershipa
 Brain Tumour Alliance Australia (BTAA)23%22%
 Cooperative Trials Group for Neuro-Oncology (COGNO)29%29%
 Clinical Oncology Society of Australia (COSA)11%13%
 Neurosurgical Society of Australasia (NSA)7%5%
 Royal College of Pathologists of Australasia (RCPA)4%3%
 Trans Tasman Radiation Oncology Group (TROG)7%8%
 Other17%18%
 Not a member of a professional society or consumer group1%1%
Round 1 (n = 54)Round 2 (n = 49)
Gender
 Female3157%3061%
 Male2241%1837%
 Other12%12%
Profession/background
 Brain Cancer Carer611%48%
 Brain Cancer Patient47%36%
 Medical Oncologist917%918%
 Neuro-Oncologist24%24%
 Neuropathologist36%36%
 Neurosurgeon611%48%
 Nurse Consultant12%12%
 Other713%714%
 Palliative Care Clinician24%24%
 Radiation Oncologist59%510%
 Radiologist12%12%
 Rehabilitation Clinician12%12%
 Research/Public Health59%510%
 Social Worker12%12%
 Trainee12%12%
Geographic location
 Metropolitan4889%4592%
 Regional611%48%
Membershipa
 Brain Tumour Alliance Australia (BTAA)23%22%
 Cooperative Trials Group for Neuro-Oncology (COGNO)29%29%
 Clinical Oncology Society of Australia (COSA)11%13%
 Neurosurgical Society of Australasia (NSA)7%5%
 Royal College of Pathologists of Australasia (RCPA)4%3%
 Trans Tasman Radiation Oncology Group (TROG)7%8%
 Other17%18%
 Not a member of a professional society or consumer group1%1%

aPanelist may have more than one membership.

Table 3.

Delphi Panelist Characteristics

Round 1 (n = 54)Round 2 (n = 49)
Gender
 Female3157%3061%
 Male2241%1837%
 Other12%12%
Profession/background
 Brain Cancer Carer611%48%
 Brain Cancer Patient47%36%
 Medical Oncologist917%918%
 Neuro-Oncologist24%24%
 Neuropathologist36%36%
 Neurosurgeon611%48%
 Nurse Consultant12%12%
 Other713%714%
 Palliative Care Clinician24%24%
 Radiation Oncologist59%510%
 Radiologist12%12%
 Rehabilitation Clinician12%12%
 Research/Public Health59%510%
 Social Worker12%12%
 Trainee12%12%
Geographic location
 Metropolitan4889%4592%
 Regional611%48%
Membershipa
 Brain Tumour Alliance Australia (BTAA)23%22%
 Cooperative Trials Group for Neuro-Oncology (COGNO)29%29%
 Clinical Oncology Society of Australia (COSA)11%13%
 Neurosurgical Society of Australasia (NSA)7%5%
 Royal College of Pathologists of Australasia (RCPA)4%3%
 Trans Tasman Radiation Oncology Group (TROG)7%8%
 Other17%18%
 Not a member of a professional society or consumer group1%1%
Round 1 (n = 54)Round 2 (n = 49)
Gender
 Female3157%3061%
 Male2241%1837%
 Other12%12%
Profession/background
 Brain Cancer Carer611%48%
 Brain Cancer Patient47%36%
 Medical Oncologist917%918%
 Neuro-Oncologist24%24%
 Neuropathologist36%36%
 Neurosurgeon611%48%
 Nurse Consultant12%12%
 Other713%714%
 Palliative Care Clinician24%24%
 Radiation Oncologist59%510%
 Radiologist12%12%
 Rehabilitation Clinician12%12%
 Research/Public Health59%510%
 Social Worker12%12%
 Trainee12%12%
Geographic location
 Metropolitan4889%4592%
 Regional611%48%
Membershipa
 Brain Tumour Alliance Australia (BTAA)23%22%
 Cooperative Trials Group for Neuro-Oncology (COGNO)29%29%
 Clinical Oncology Society of Australia (COSA)11%13%
 Neurosurgical Society of Australasia (NSA)7%5%
 Royal College of Pathologists of Australasia (RCPA)4%3%
 Trans Tasman Radiation Oncology Group (TROG)7%8%
 Other17%18%
 Not a member of a professional society or consumer group1%1%

aPanelist may have more than one membership.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close